NCT01433237已完成不适用
A Retrospective Study on the Diagnostic Value of Serum miR-206 in Rhabdomyosarcoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 主要终点
- Serum miR-206 as a biomarker for RMS
研究概览
简要总结
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies biomarkers in samples from patients with rhabdomyosarcoma.
详细描述
OBJECTIVES:
- Determine whether circulating muscle-specific microRNAs, especially serum miR-206, are potential biomarkers for rhabdomyosarcoma (RMS).
OUTLINE: Archived serum samples are analyzed for miR-206 expression.
PROJECTED ACCRUAL: A total of 15 samples from patients with alveolar rhabdomyosarcoma (RMS), 15 from patients with embryonal RMS, and 10 from patients without RMS will be accrued for this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Serum miR-206 as a biomarker for RMS
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
DNA Variations in the Gene in Young Patients With Wilms' TumorKidney CancerNCT00088803Children's Oncology Group471
已完成
不适用
Trastuzumab in Treating Women With Metastatic Breast CancerBreast CancerNCT00896376Centre Antoine Lacassagne49
已完成
不适用
Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal CancerMetastatic CancerColorectal CancerNCT00899210University Hospital, Grenoble75
已完成
不适用
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaKidney CancerMelanoma (Skin)NCT00617799University of Nebraska15
终止
不适用
Blood Samples From Patients on a Clinical Trial to CINV During HSCTChronic Myeloproliferative DisordersGestational Trophoblastic TumorBreast CancerMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNausea and VomitingLymphomaLeukemiaTesticular Germ Cell TumorOvarian CancerNeuroblastomaNCT00900068OHSU Knight Cancer Institute9